CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, ...

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, ...

(MENAFN- GlobeNewsWire - Nasdaq) CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for ...

Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...

On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...

Leerink Global Healthcare Conference 2026 March 11, 2026 8:00 AM EDTCompany ParticipantsSam Samad - Executive VP ...

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

Dr. Carolyn Mukai, ND, Dr. Lynn Klassen, ND, Dr. Ece Toprak, ND Expanding recognition of infection-triggered ...

Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...